CARNITENE

This brand name is authorized in Estonia, Hong Kong, Croatia, Italy, Netherlands

Active ingredients

The drug CARNITENE contains one active pharmaceutical ingredient (API):

1 L-carnitine UNII 0G389FZZ9M - LEVOCARNITINE

Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides. Read about L-carnitine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AA01	Levocarnitine	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1153561, 1238914, 1621471, 1777619, 1782132
Country: HK	Department of Health Drug Office	Identifier(s): 36344
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-024622959, HR-H-412161189
Country: IT	Agenzia del Farmaco	Identifier(s): 018610079
Country: NL	Z-Index G-Standaard	Identifier(s): 12822353, 12822361
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 23337, 23345, 24716